Table S1 Base case scenario of overall survival and progression-free survival in patients with PD-L1 TPS≥1% before matching Table S2 Landmark analysis of overall su
The expression of PD-L1 was evaluated by flow cytometric analysis using anti-PD-L1 mAb 4G12-C1. -; 60% positive.*Cells were incubated with recombinant canine IFN-γ (100 ng/ml) for 24 h before the anal
Table lists the results of William’s t-test to test for significant difference in the Spearman correlation coefficients between PD-L1 mRNA transcript or pathologist H-score and different DIA endpoints
Background Tumor cells express programmed death ligand 1 (PD-L1) and is a key immune evasion mechanism. PD-L1 expression in multiple breast cancer cell lines was evaluated to identify intrinsic differ
